Biomarkers of Atherosclerosis: Is the Evaluation Essential Preoperatively?
Received Date: May 27, 2017 / Accepted Date: Aug 17, 2017 / Published Date: Aug 21, 2017
Atherosclerosis is a chronic inflammatory condition leading to various cardiovascular as well as cerebrovascular events and peripheral vascular disease (PVD). Presence of significant atherosclerosis leads to perioperative adverse events, morbidity and mortality in the high risk surgical population. The usual methods for evaluating the like hood of adverse cardiovascular or cerebrovascular events postoperatively in these set of patients depends primarily on scoring system and functional status of the cardiovascular system during preoperative assessment. The pre-existing disease activity and possible postoperative adverse cardiovascular event (CVE) can be estimated to some degree from the preoperative levels of biomarkers associated with atherosclerosis.
This mini-review summarizes the potential role of biomarkers related to the atherosclerosis process in the cardiovascular risk stratification of patients undergoing non cardiac surgery. A Med Line search of literature on atherosclerosis biomarkers in the perioperative period and adverse post-operative cardiovascular event was conducted; and thirty-three reports are added to this review.
Keywords: Atherosclerosis; Perioperative period; Biomarkers
Citation: Choudhury M, Devagourou V (2017) Biomarkers of Atherosclerosis: Is the Evaluation Essential Preoperatively?. Atheroscler Open Access 2: 116.
Copyright: ©2017 Choudhury M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
- Total views: 2349
- [From(publication date): 0-2017 - Aug 04, 2020]
- Breakdown by view type
- HTML page views: 2171
- PDF downloads: 178